Gsk Share Discussion Threads

[pol123] 25/8/2022 16:15

Mass underpermance may it end soon AZ striding on.

[pol123] 25/8/2022 16:12

Poor performance may lead to a low ball offer. Not welcome, expect many investors, booth IIs and PIs are under water. Chair and CEO close to the chop???

[pol123] 25/8/2022 16:09

A ceo should be measured and paid on performance. Make your mind up over paid under performed?'hmmmm

[lippy4] 25/8/2022 13:46

can i have one of these jobs as i would only stay a year and i could not do more damage than has already been done...

[tradermichael] 25/8/2022 13:24

Its about 'added value', isn't it?

Boris Johnson's earnings are made up of £79,936 for his role as Prime Minister, and an additional £84,144 for being an MP. Manchester United footballer and political campaigner, Marcus Rashford is paid £10.4 million.

Emma, Boris, Marcus ..... who adds most value?

[pierre oreilly] 25/8/2022 13:02

No wonder rail workers and uncle tom cobley are striking for 6% when they see cataclysmic bosses getting 17% (to 10mill) for mass company destruction. Can't we pay her 9 mill to stay at home?

[tradermichael] 25/8/2022 12:41

Emma Walmsley received a 17% pay rise, making £8.2 million pounds ($10.88 million) last year.

Worth it??

[supermarky] 25/8/2022 11:04

A close below the recent lows will confirm my thoughts. Just my opinion. What do I know...

[supermarky] 25/8/2022 11:02

the share price seems to be struggling to hold this support area. It looks like more falls to me. Unbelievable but it is lile catching a falling knife here at the moment. Silly season will present some good opportunities to top up and build positions

[berny3] 24/8/2022 15:49

with the yield over 4% and expectations of a rising dividend. compared to where the company was previously on a 5% yield and over committed on the dividend there is value here. After selling out prior to split and buying now back in. anything sub £15 is good value.

No idea where the bottom is, but August volumes are low so most things are trading defensively and sideways. In a recession pharms are still needed and they can weather that storm quite well. good luck all.

[maywillow] 24/8/2022 15:27

MONEYWEEK


Are GSK’s legal troubles a threat to the firm’s survival?
Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargreaves looks at how it might affect the business's prospects.
by: Rupert Hargreaves


Over the past week, GSK (LSE: GSK) shares have fallen off a cliff. The FTSE 100 company has seen its market value plunge 17% and recent spin-off Haleon (LSE: HLN) has followed suit, plunging 14%.

We don’t have to look far to understand why investors have been running for the hills. It all comes back to a drug called Zantac, an over-the-counter heartburn drug that was pulled from sale in 2019.
A legacy drug comes back to haunt GSK

GSK launched Zantac in 1981 as a prescription medication and it went on to become an over-the-counter treatment in the mid-90s. Now there’s a bit of a corporate paper trail to get through here to explain what happened next.

[supermarky] 24/8/2022 15:11

Yes i have funds ready to add to my position on any further weakness. After having no exposure to gsk until recently i am building up my position. Underwater at the minute but this is all seen as an investment with a decent dividend in a sector i had no exposure to. I would love to add on any weakness and keep drip buying

[wall street trader] 24/8/2022 14:01

If this drops to £12 which I think unlikely it's a great income stock that's not going any where soon

[spyder] 24/8/2022 11:31

Hi all
I agree that <£14 offers an astonishingly good price to build/add to a holding in GSK, however, my quandary is that it may go lower still before we can put this behind us and focus on RSV, shingles etc etc.

[berny3] 24/8/2022 11:23

anhar agree

[anhar] 24/8/2022 11:07

Claims against drug companies many years later regarding deaths or illnesses supposedly caused by their products are one of the risks of this business. It is certain to happen from time to time so this isn't the first and won't be the last. The only way for investors to avoid this is to refuse to hold such shares.

In my view it provides opportunity to acquire the stock at a depressed price due to the market's negative over reaction to the potential liabilities. Whether the claims are true and successful or not is almost beside the point.

There are a few industries like drugs which are prone to periodic crises which depress their shares for a time. For example oil and mining which occasionally suffer major spills and collapses etc.

This doesn't deter me from holding such shares because my income port is very widely diversified and provided I don't overweight these sectors and have the cash available, I'm inclined to add when these events occur.

[jonjoneil] 24/8/2022 10:24

net
I think you are being a bit hard. GSK was in recession before it became global.

[alibizzle] 24/8/2022 09:44

Porsche is just a troll , posting same pointless rant on other LSE forum , pretty sad really

[netcurtains] 24/8/2022 09:16

Entire global stockmarket tanking and same idiots on this board blame the GSK directors for global recession.
Talk about crazy investors.

[jonjoneil] 24/8/2022 09:05

If you want to know the latest share price, don't look at the GSK website. They haven't updated the UK market price. Current price showing £14.25 at close on the 19th. Are they trying to hide something?

[spoole5] 24/8/2022 08:21

Board change but not the one that's needed

[tradermichael] 23/8/2022 13:59

Can't agree less!

[porsche1945] 23/8/2022 13:49

@traderM. Well they would say that wouldnt they? How is this still over 14 quid. Guessing sub 12 soon, whole UK and its indexes heading for toilet anyway with sterling collapsing nobody wants U.K. assets but gsk in the shxt with this, its been known for an age there has been issues with various cancers from ranitidine. The stuff is poison and causes other issues as well. Years this will go on for.